A hospital antimicrobial stewardship committee reviews prescribing data for surgical prophylaxis and finds that 68% of patients undergoing elective colorectal surgery receive prophylactic antibiotics that continue beyond 24 hours post-operatively, despite local and national guidelines recommending single-dose or maximum 24-hour prophylaxis. The surgical team argues that their infection rates are low and changing practice might increase surgical site infections. Which evidence-based principle best supports the antimicrobial stewardship team's recommendation to reduce prophylaxis duration?
Q22
A 68-year-old woman with end-stage renal failure on haemodialysis (Monday-Wednesday-Friday schedule) presents on a Saturday morning with fever, rigors, and a painful, fluctuant swelling at her arteriovenous fistula site in the left forearm. Examination reveals a 3cm tender, erythematous, fluctuant mass with surrounding cellulitis extending 5cm along the forearm. Her temperature is 38.9°C, blood pressure 142/88 mmHg, and heart rate 102 bpm. Blood cultures are taken. What is the most appropriate antibiotic regimen while awaiting culture results?
Q23
A 51-year-old man is admitted with community-acquired pneumonia and commenced on intravenous co-amoxiclav 1.2g three times daily. On day 3, he is clinically improved with temperature 37.2°C, respiratory rate 16/min, oxygen saturations 96% on room air, and he is eating and drinking normally. Blood tests show WCC 9.2 × 10⁹/L (down from 16.8 on admission) and CRP 42 mg/L (down from 168 on admission). According to the 'Start Smart - Then Focus' antimicrobial stewardship framework, what is the most appropriate management at this stage?
Q24
A 47-year-old woman with a BMI of 41 kg/m² presents with a 36-hour history of severe pain, swelling, and discolouration of her right thigh. She reports initial symptoms started as a small red area following a minor scratch 3 days ago. On examination, the affected area is dusky red with purple discolouration, there are bullae present, and she has severe pain disproportionate to the clinical findings. There is crepitus palpable in the tissue. Her temperature is 39.1°C, heart rate 118 bpm, blood pressure 98/62 mmHg, and she appears confused. Blood tests show WCC 22.4 × 10⁹/L, CRP 285 mg/L, creatinine 178 μmol/L, and lactate 4.2 mmol/L. What is the most critical immediate management priority?
Q25
A hospital trust implements a new antimicrobial stewardship intervention whereby all patients prescribed carbapenems must have the prescription reviewed and authorised by a consultant microbiologist or infectious diseases physician within 24 hours. After 12 months, audit data shows a 35% reduction in carbapenem consumption, but there has been a corresponding 28% increase in piperacillin-tazobactam use and no change in overall antimicrobial consumption. What does this pattern most likely represent?
Q26
A 62-year-old man with chronic venous insufficiency and lymphoedema of both lower limbs presents with his fifth episode of right leg cellulitis in 18 months. Each episode has required hospital admission for intravenous antibiotics. He is currently well with no active infection. His BMI is 32 kg/m², and he has well-controlled type 2 diabetes (HbA1c 52 mmol/mol). Skin swabs from previous episodes have grown beta-haemolytic streptococci (not group A). What is the most appropriate long-term prophylactic antibiotic strategy for this patient?
Q27
A 43-year-old man who works as a plumber presents with a 4-day history of a progressively enlarging, tender abscess on his left forearm. He reports having sustained a minor puncture wound from a rusty nail while working 10 days ago. On examination, there is a 4cm fluctuant, erythematous swelling with surrounding cellulitis extending 2cm beyond the abscess margin. His temperature is 37.8°C. Incision and drainage is performed, yielding 15ml of purulent material. What is the most appropriate antibiotic management following the drainage procedure?
Q28
A hospital antimicrobial stewardship team reviews quarterly audit data and identifies that the average duration of intravenous antibiotic therapy for uncomplicated community-acquired pneumonia on the medical wards is 7 days, despite most patients showing clinical improvement by day 3. Microbiological cultures are positive in only 15% of cases. Which antimicrobial stewardship intervention would be most appropriate to address this finding?
Q29
A 55-year-old woman with type 2 diabetes presents to the Emergency Department with a 3-day history of a painful, red, swollen right lower leg. On examination, there is a well-demarcated area of erythema extending from the ankle to mid-calf with associated warmth and tenderness. Her temperature is 38.2°C, heart rate 95 bpm, and blood pressure 135/82 mmHg. Blood tests show WCC 13.2 × 10⁹/L and CRP 78 mg/L. What is the recommended first-line antibiotic treatment for this patient according to current UK guidance?
Q30
A 39-year-old man who works as a marine biologist presents with a 5-day history of multiple painless papular lesions on both hands and forearms that have progressed to form violaceous nodules. He reports regular handling of sea urchins and coral samples. The lesions have a verrucous appearance and do not respond to a 3-day course of flucloxacillin. He is otherwise well with no systemic symptoms. What is the most likely causative organism?
Common Infections UK Medical PG Practice Questions and MCQs
Question 21: A hospital antimicrobial stewardship committee reviews prescribing data for surgical prophylaxis and finds that 68% of patients undergoing elective colorectal surgery receive prophylactic antibiotics that continue beyond 24 hours post-operatively, despite local and national guidelines recommending single-dose or maximum 24-hour prophylaxis. The surgical team argues that their infection rates are low and changing practice might increase surgical site infections. Which evidence-based principle best supports the antimicrobial stewardship team's recommendation to reduce prophylaxis duration?
A. Prolonged prophylaxis beyond 24 hours has no additional benefit in reducing surgical site infections but significantly increases Clostridioides difficile risk (Correct Answer)
B. Shorter courses of prophylaxis are more cost-effective and patient satisfaction scores are higher with reduced antibiotic exposure
C. Extended prophylaxis leads to antibiotic resistance in the patient's microbiome which increases their risk of future MRSA colonisation
D. Single-dose prophylaxis is easier for nursing staff to administer and reduces medication errors on surgical wards
E. The current low infection rate is likely due to other factors such as surgical technique and continuing antibiotics will eventually lead to resistance
Explanation: ***Prolonged prophylaxis beyond 24 hours has no additional benefit in reducing surgical site infections but significantly increases Clostridioides difficile risk***- Numerous studies confirm that extending **surgical prophylaxis** beyond 24 hours provides no additional protection against **surgical site infections (SSIs)**.- However, this prolonged exposure significantly elevates the risk of **Clostridioides difficile infection** and other antibiotic-associated toxicities like acute kidney injury.*Shorter courses of prophylaxis are more cost-effective and patient satisfaction scores are higher with reduced antibiotic exposure*- While **cost-effectiveness** and potentially higher **patient satisfaction** are positive outcomes of reduced antibiotic use, they are secondary benefits.- These factors are important for healthcare economics and patient experience, but not the primary **evidence-based clinical principle** dictating prophylaxis duration regarding patient harm.*Extended prophylaxis leads to antibiotic resistance in the patient's microbiome which increases their risk of future MRSA colonisation*- Prolonged antibiotic use does disrupt the **patient's microbiome** and contributes to **antibiotic resistance** development over time.- However, the immediate and direct evidence-based concern in the postoperative period is the increased risk of **Clostridioides difficile infection**, which is a more acute and well-documented adverse outcome than future MRSA colonization.*Single-dose prophylaxis is easier for nursing staff to administer and reduces medication errors on surgical wards*- Easing administrative burden for **nursing staff** and reducing **medication errors** are valid operational benefits.- These are logistical advantages rather than the fundamental **evidence-based clinical rationale** for changing antibiotic duration to improve patient outcomes and safety.*The current low infection rate is likely due to other factors such as surgical technique and continuing antibiotics will eventually lead to resistance*- Attributing a low infection rate solely to **surgical technique** is speculative and does not address the lack of proven benefit for extended antibiotics.- While **antibiotic resistance** is a critical long-term concern, the most direct and immediate evidence-based principle for reducing duration focuses on the lack of additional benefit in preventing **SSIs** and the increased risk of **Clostridioides difficile**.
Question 22: A 68-year-old woman with end-stage renal failure on haemodialysis (Monday-Wednesday-Friday schedule) presents on a Saturday morning with fever, rigors, and a painful, fluctuant swelling at her arteriovenous fistula site in the left forearm. Examination reveals a 3cm tender, erythematous, fluctuant mass with surrounding cellulitis extending 5cm along the forearm. Her temperature is 38.9°C, blood pressure 142/88 mmHg, and heart rate 102 bpm. Blood cultures are taken. What is the most appropriate antibiotic regimen while awaiting culture results?
A. Intravenous flucloxacillin 2g four times daily with dose adjustment for renal function
B. Intravenous vancomycin 1g loading dose then dosing according to levels post-dialysis
C. Intravenous teicoplanin loading dose 800mg followed by levels-guided maintenance (Correct Answer)
D. Oral co-amoxiclav 625mg three times daily with incision and drainage only
E. Intravenous daptomycin 500mg once daily with no dose adjustment required
Explanation: ***Intravenous teicoplanin loading dose 800mg followed by levels-guided maintenance***- **Teicoplanin** is the preferred glycopeptide in hemodialysis patients because it is **not significantly removed by hemodialysis**, allowing for more stable levels and convenient dosing (e.g., once daily or every other day) without complex post-dialysis adjustments.- It provides essential **Gram-positive coverage**, including **MRSA**, which is a high-risk pathogen in vascular access infections for dialysis patients, necessitating empirical coverage.*Intravenous flucloxacillin 2g four times daily with dose adjustment for renal function*- Flucloxacillin does not provide coverage for **MRSA**, which must be empirically covered in a hemodialysis patient with a fistula site infection.- High-dose flucloxacillin in end-stage renal failure increases the risk of **neurotoxicity** and requires frequent dosing, making it less ideal than glycopeptides.*Intravenous vancomycin 1g loading dose then dosing according to levels post-dialysis*- Vancomycin is **partially cleared by modern high-flux hemodialysis** membranes, necessitating complex timing around dialysis sessions and frequent level monitoring.- While it covers MRSA, the risk of sub-therapeutic dosing between dialysis sessions (especially over a long weekend) makes **teicoplanin** a superior choice for maintaining stable drug levels.*Oral co-amoxiclav 625mg three times daily with incision and drainage only*- Oral therapy is insufficient for a patient presenting with **systemic inflammatory response syndrome (SIRS)** symptoms like fever (38.9°C) and rigors, indicating a severe infection.- Arteriovenous fistula infections are high-risk for **bacteremia** and endocarditis, requiring immediate, high-bioavailability **intravenous antibiotics**.*Intravenous daptomycin 500mg once daily with no dose adjustment required*- Daptomycin actually **requires significant dose adjustment** (usually given every 48 hours) in patients with a creatinine clearance of less than 30 mL/min or those on dialysis.- While effective against MRSA, it is generally reserved for cases where glycopeptides are contraindicated or in specific **VRE** infections, and the claim of no dose adjustment is incorrect.
Question 23: A 51-year-old man is admitted with community-acquired pneumonia and commenced on intravenous co-amoxiclav 1.2g three times daily. On day 3, he is clinically improved with temperature 37.2°C, respiratory rate 16/min, oxygen saturations 96% on room air, and he is eating and drinking normally. Blood tests show WCC 9.2 × 10⁹/L (down from 16.8 on admission) and CRP 42 mg/L (down from 168 on admission). According to the 'Start Smart - Then Focus' antimicrobial stewardship framework, what is the most appropriate management at this stage?
A. Continue intravenous co-amoxiclav for a total of 7 days as per standard pneumonia protocol
B. Switch to oral co-amoxiclav 625mg three times daily and review response in 24 hours (Correct Answer)
C. Stop antibiotics as the patient has completed 72 hours of therapy and is clinically well
D. Continue intravenous antibiotics but reduce frequency to twice daily dosing
E. Switch to oral clarithromycin monotherapy for atypical organism coverage
Explanation: ***Switch to oral co-amoxiclav 625mg three times daily and review response in 24 hours***
- The patient meets criteria for **IV-to-oral switch (IVOS)**: he is clinically stable, **apyrexial**, improving inflammatory markers (**CRP and WCC**), and able to tolerate oral intake.
- Early IVOS is a cornerstone of the **'Start Smart – Then Focus'** framework, reducing **cannula-related infections** and facilitating earlier hospital discharge.
*Continue intravenous co-amoxiclav for a total of 7 days as per standard pneumonia protocol*
- Continuing **intravenous therapy** unnecessarily increases the risk of **thrombophlebitis** and bacteremia when clinical oral absorption is sufficient.
- Standard protocol mandates a review at **48-72 hours** to de-escalate treatment based on clinical response, rather than sticking to a fixed IV duration.
*Stop antibiotics as the patient has completed 72 hours of therapy and is clinically well*
- While the patient is improving, a **3-day course** is generally insufficient for community-acquired pneumonia requiring hospitalization; a total of **5-7 days** is typically recommended.
- **Premature cessation** of antibiotics before the full clinical course is completed increases the risk of **relapse** or treatment failure.
*Continue intravenous antibiotics but reduce frequency to twice daily dosing*
- Reducing the frequency of **IV co-amoxiclav** is not a standard pharmacokinetic approach and results in **sub-therapeutic levels** of the drug.
- The priority in antimicrobial stewardship is to change the **route of administration** rather than adjusting frequency of a currently indicated IV drug.
*Switch to oral clarithromycin monotherapy for atypical organism coverage*
- There is no clinical or microbiological indication to switch to **monotherapy** with a different class when the patient is already responding well to **co-amoxiclav**.
- Antimicrobial stewardship encourages sticking to effective therapy; switching to **clarithromycin** without cause may provide inadequate coverage for the primary pathogen.
Question 24: A 47-year-old woman with a BMI of 41 kg/m² presents with a 36-hour history of severe pain, swelling, and discolouration of her right thigh. She reports initial symptoms started as a small red area following a minor scratch 3 days ago. On examination, the affected area is dusky red with purple discolouration, there are bullae present, and she has severe pain disproportionate to the clinical findings. There is crepitus palpable in the tissue. Her temperature is 39.1°C, heart rate 118 bpm, blood pressure 98/62 mmHg, and she appears confused. Blood tests show WCC 22.4 × 10⁹/L, CRP 285 mg/L, creatinine 178 μmol/L, and lactate 4.2 mmol/L. What is the most critical immediate management priority?
A. Urgent CT scan of the affected limb to determine extent of tissue involvement
B. Immediate empirical broad-spectrum antibiotics including clindamycin and urgent surgical consultation (Correct Answer)
C. Blood cultures followed by intravenous flucloxacillin and close observation
D. Fascial biopsy and tissue culture to guide targeted antibiotic therapy
E. Aggressive fluid resuscitation and transfer to high-dependency unit for monitoring
Explanation: ***Immediate empirical broad-spectrum antibiotics including clindamycin and urgent surgical consultation***
- This patient presents with classic signs of **necrotising fasciitis (NF)**, including **pain disproportionate to findings**, **crepitus**, and **hemodynamic instability**, which requires urgent **surgical debridement**.
- **Clindamycin** is essential as it acts as a **protein synthesis inhibitor**, effectively neutralizing the **exotoxins** produced by pathogens like Group A Streptococcus and Staphylococcus aureus.
*Urgent CT scan of the affected limb to determine extent of tissue involvement*
- While CT imaging can show **subcutaneous gas** or fascial thickening, it must **never delay** the time-to-surgery in a clinically evident case like this.
- The diagnosis of NF is primarily **clinical**; waiting for imaging in the presence of **septic shock** and **crepitus** increases mortality risks.
*Blood cultures followed by intravenous flucloxacillin and close observation*
- **Flucloxacillin** alone is inadequate as it lacks coverage for **anaerobes** and the **polymicrobial nature** (Type I NF) often seen in patients with high BMI or comorbidities.
- "Close observation" is inappropriate for an **acute surgical emergency** that carries a mortality rate of 20-40% if not managed aggressively.
*Fascial biopsy and tissue culture to guide targeted antibiotic therapy*
- Targeted therapy is a later goal; **empirical broad-spectrum coverage** is mandatory at presentation to combat life-threatening sepsis.
- Waiting for **culture results** would result in fatal delays, as NF can spread at a rate of several centimeters per hour.
*Aggressive fluid resuscitation and transfer to high-dependency unit for monitoring*
- While **fluid resuscitation** is a critical component of the **Sepsis Six** bundle, it is supportive and does not address the underlying source of infection.
- Definite management requires **source control** (surgery), which cannot be replaced by monitoring in an HDU or ICU setting.
Question 25: A hospital trust implements a new antimicrobial stewardship intervention whereby all patients prescribed carbapenems must have the prescription reviewed and authorised by a consultant microbiologist or infectious diseases physician within 24 hours. After 12 months, audit data shows a 35% reduction in carbapenem consumption, but there has been a corresponding 28% increase in piperacillin-tazobactam use and no change in overall antimicrobial consumption. What does this pattern most likely represent?
A. Successful antimicrobial stewardship demonstrating appropriate antibiotic selection
B. Antibiotic substitution effect without genuine stewardship benefit (Correct Answer)
C. Appropriate response to changing local resistance patterns
D. Evidence of improved microbiological sampling leading to targeted therapy
E. Carbapenem-sparing strategy consistent with best practice guidelines
Explanation: ***Antibiotic substitution effect without genuine stewardship benefit***
- This phenomenon, often termed the **'squeeze the balloon' effect**, occurs when restricting one class of antibiotics leads to a compensatory increase in the use of another class.
- Because **total antimicrobial consumption** remains unchanged, the intervention has failed to promote true **de-escalation** or eliminate unnecessary use, merely shifting the selective pressure to **piperacillin-tazobactam**.
*Successful antimicrobial stewardship demonstrating appropriate antibiotic selection*
- Success in stewardship is measured by the **optimization of therapy** and a reduction in inappropriate use, not just shifting between broad-spectrum agents.
- The lack of change in **overall consumption** suggests that clinical decision-making regarding the necessity of broad-spectrum coverage has not improved.
*Appropriate response to changing local resistance patterns*
- There is no data provided suggesting a shift in **antibiograms** or an increase in infections necessitating **piperacillin-tazobactam** over carbapenems.
- The direct temporal link between the **new policy** and the shift in prescribing strongly points to a behavioral response rather than an epidemiological shift.
*Evidence of improved microbiological sampling leading to targeted therapy*
- Improved sampling and **targeted therapy** should ideally lead to a decrease in overall broad-spectrum use as patients are switched to narrow-spectrum agents.
- Replacing one **broad-spectrum empiric agent** (carbapenem) with another (piperacillin-tazobactam) indicates that therapy remains non-targeted.
*Carbapenem-sparing strategy consistent with best practice guidelines*
- While **carbapenem-sparing** is a goal for managing **ESBL-producing organisms**, it should be part of a broader strategy that reduces the total ecological burden of antibiotics.
- Merely substituting agents without addressing **total volume of use** does not align with best practices for limiting the development of **multidrug-resistant organisms**.
Question 26: A 62-year-old man with chronic venous insufficiency and lymphoedema of both lower limbs presents with his fifth episode of right leg cellulitis in 18 months. Each episode has required hospital admission for intravenous antibiotics. He is currently well with no active infection. His BMI is 32 kg/m², and he has well-controlled type 2 diabetes (HbA1c 52 mmol/mol). Skin swabs from previous episodes have grown beta-haemolytic streptococci (not group A). What is the most appropriate long-term prophylactic antibiotic strategy for this patient?
A. Oral penicillin V 250-500mg once daily (Correct Answer)
B. Oral flucloxacillin 250mg twice daily
C. Oral co-amoxiclav 625mg once daily
D. Oral erythromycin 250mg twice daily
E. Rotating courses of different antibiotics every 2 months
Explanation: ***Oral penicillin V 250-500mg once daily***
- Long-term **antibiotic prophylaxis** is indicated for patients who have experienced **two or more episodes** of cellulitis within a 12-month period, especially with risk factors like **lymphoedema** and **chronic venous insufficiency**.
- **Penicillin V** (phenoxymethylpenicillin) is the first-line choice because it specifically targets **beta-haemolytic streptococci**, which were identified in previous skin swabs and are the most common cause of recurrent cellulitis in this setting.
*Oral flucloxacillin 250mg twice daily*
- While effective for acute **Staphylococcus aureus** infections, **flucloxacillin** is less effective than penicillin V for long-term prophylaxis against **beta-haemolytic streptococci**.
- Guidelines specifically recommend **phenoxymethylpenicillin** (Penicillin V) over flucloxacillin for the prevention of recurrent streptococcal skin infections.
*Oral co-amoxiclav 625mg once daily*
- This provides an unnecessarily **broad spectrum** of coverage, including gram-negative and anaerobic organisms, which is not required for standard prophylaxis against **streptococci**.
- Its use increases the risk of **antimicrobial resistance** and healthcare-associated infections like ***Clostridioides difficile***, making it inappropriate for routine prophylaxis.
*Oral erythromycin 250mg twice daily*
- This is a secondary option reserved specifically for patients with a documented **penicillin allergy**.
- In non-allergic patients, **penicillin V** is preferred due to superior efficacy, narrower spectrum, and a more favorable side-effect profile regarding gastrointestinal tolerance.
*Rotating courses of different antibiotics every 2 months*
- There is no clinical evidence to support **rotating antibiotics** as a standard strategy for preventing recurrent soft tissue infections.
- This approach is more likely to drive **multidrug resistance** and complicates the management of breakthrough infections, without providing additional benefit.
Question 27: A 43-year-old man who works as a plumber presents with a 4-day history of a progressively enlarging, tender abscess on his left forearm. He reports having sustained a minor puncture wound from a rusty nail while working 10 days ago. On examination, there is a 4cm fluctuant, erythematous swelling with surrounding cellulitis extending 2cm beyond the abscess margin. His temperature is 37.8°C. Incision and drainage is performed, yielding 15ml of purulent material. What is the most appropriate antibiotic management following the drainage procedure?
A. No antibiotics required as adequate drainage has been achieved
B. Oral flucloxacillin 500mg four times daily for 7 days (Correct Answer)
C. Intravenous co-amoxiclav 1.2g three times daily for 5 days
D. Oral metronidazole 400mg three times daily for 7 days
E. Intramuscular benzylpenicillin 1.2g immediately followed by oral phenoxymethylpenicillin
Explanation: ***Oral flucloxacillin 500mg four times daily for 7 days***- Antibiotics are indicated following incision and drainage (I&D) when there is **associated cellulitis** extending beyond the abscess margin or systemic upset.- **Oral flucloxacillin** is the first-line choice to target the most common skin pathogens, **Staphylococcus aureus** and **Streptococcus pyogenes**.*No antibiotics required as adequate drainage has been achieved*- While simple abscesses without systemic symptoms or cellulitis can be managed with I&D alone, this patient has **surrounding cellulitis** and a fever.- The guidelines recommend antimicrobial therapy when the **erythema** extends significantly beyond the abscess wall.*Intravenous co-amoxiclav 1.2g three times daily for 5 days*- **Intravenous antibiotics** are generally reserved for patients with severe sepsis, rapidly progressing infection, or those unable to tolerate oral medication.- Co-amoxiclav is unnecessarily **broad-spectrum** for a localized skin abscess in a patient who is hemodynamically stable.*Oral metronidazole 400mg three times daily for 7 days*- Metronidazole treats **anaerobic infections** but lacks the necessary activity against the **gram-positive cocci** (staphylococci and streptococci) typical of skin abscesses.- It is not indicated for standard cutaneous abscesses unless there is evidence of specific anaerobic involvement, such as a **foul odor** or origin in the perineal region.*Intramuscular benzylpenicillin 1.2g immediately followed by oral phenoxymethylpenicillin*- **Benzylpenicillin** and phenoxymethylpenicillin have a narrow spectrum and are ineffective against **beta-lactamase-producing** S. aureus (common in abscesses).- These agents are primarily used for confirmed **Group A Streptococcal** infections like erysipelas, rather than staphylococcal-dominant abscesses.
Question 28: A hospital antimicrobial stewardship team reviews quarterly audit data and identifies that the average duration of intravenous antibiotic therapy for uncomplicated community-acquired pneumonia on the medical wards is 7 days, despite most patients showing clinical improvement by day 3. Microbiological cultures are positive in only 15% of cases. Which antimicrobial stewardship intervention would be most appropriate to address this finding?
A. Implement automatic stop orders for all antibiotics after 5 days
B. Introduce a mandatory 48-72 hour review policy with emphasis on IV-to-oral switch criteria (Correct Answer)
C. Require infectious diseases consultation for all pneumonia cases before antibiotic initiation
D. Replace all intravenous antibiotics with oral formulations at admission
E. Mandate blood cultures and sputum cultures before any antibiotic prescription
Explanation: ***Introduce a mandatory 48-72 hour review policy with emphasis on IV-to-oral switch criteria***
- This intervention directly addresses the audit finding of prolonged **intravenous (IV) antibiotic duration** despite **early clinical improvement**, facilitating a timely transition to oral therapy.
- It aligns with **antimicrobial stewardship principles** by requiring reassessment of IV therapy necessity and promoting the **IV-to-oral switch**, which reduces hospital stay and **catheter-related complications**.
*Implement automatic stop orders for all antibiotics after 5 days*
- This approach is overly rigid and could lead to **premature cessation** of antibiotics, potentially jeopardizing patient outcomes, especially for those with a slower clinical response.
- **Individualized patient assessment** for treatment duration is crucial, as an arbitrary stop order does not account for clinical variability.
*Require infectious diseases consultation for all pneumonia cases before antibiotic initiation*
- This strategy is **resource-intensive and impractical** for all cases of uncomplicated community-acquired pneumonia (CAP) in a general hospital setting.
- While beneficial for complex cases, it is not an efficient or scalable intervention to address the specific issue of **prolonged IV duration** in clinically stable patients.
*Replace all intravenous antibiotics with oral formulations at admission*
- This approach disregards the initial **clinical severity** and the need for **high bioavailability** and rapid systemic levels often required for hospitalized patients with pneumonia.
- Many patients admitted for pneumonia require initial **IV therapy** to achieve adequate drug concentrations, especially if they are acutely ill or have impaired gastrointestinal absorption.
*Mandate blood cultures and sputum cultures before any antibiotic prescription*
- Although important for diagnosis and guiding therapy, the problem highlighted is the **duration of IV therapy** in clinically improving patients, not primarily the initial diagnostic workup.
- The scenario states that microbiological cultures are positive in only 15% of cases, indicating that even if mandated, cultures would often not provide the specific guidance needed to significantly shorten **IV treatment duration** in most uncomplicated CAP patients.
Question 29: A 55-year-old woman with type 2 diabetes presents to the Emergency Department with a 3-day history of a painful, red, swollen right lower leg. On examination, there is a well-demarcated area of erythema extending from the ankle to mid-calf with associated warmth and tenderness. Her temperature is 38.2°C, heart rate 95 bpm, and blood pressure 135/82 mmHg. Blood tests show WCC 13.2 × 10⁹/L and CRP 78 mg/L. What is the recommended first-line antibiotic treatment for this patient according to current UK guidance?
A. Oral flucloxacillin 500mg four times daily
B. Intravenous flucloxacillin 1-2g four times daily (Correct Answer)
C. Oral co-amoxiclav 625mg three times daily
D. Intravenous vancomycin 1g twice daily
E. Oral doxycycline 200mg loading dose then 100mg twice daily
Explanation: ***Intravenous flucloxacillin 1-2g four times daily***
- This patient exhibits **systemic features** (fever, tachycardia, raised WCC/CRP), classifying this as **Eron Class III cellulitis**, which requires **intravenous antibiotics**.
- **Flucloxacillin** is the first-line empirical choice as it effectively targets the most common pathogens, **Staphylococcus aureus** and **Streptococcus pyogenes**.
*Oral flucloxacillin 500mg four times daily*
- This is the treatment of choice for **Class I or II cellulitis** where the patient is systemically well and has no significant comorbidities.
- Given the **fever (38.2°C)** and significantly **raised inflammatory markers**, oral therapy is considered insufficient for initial management in this case.
*Oral co-amoxiclav 625mg three times daily*
- **Co-amoxiclav** is not first-line for uncomplicated cellulitis and is typically reserved for cases involving **human or animal bites** or facial involvement.
- Using a **broad-spectrum antibiotic** like this unnecessarily increases the risk of resistance and **Clostridioides difficile** infection.
*Intravenous vancomycin 1g twice daily*
- **Vancomycin** is indicated only if there is a known **penicillin allergy** or a high suspicion of **MRSA infection**.
- There are no risk factors mentioned for MRSA, and the patient has no documented allergy to **beta-lactams**.
*Oral doxycycline 200mg loading dose then 100mg twice daily*
- **Doxycycline** serves as an alternative for patients with **penicillin allergy**, but intravenous therapy is still preferred for systemic illness.
- The route is inappropriate for a patient with **systemic inflammatory response** signs, and it does not provide the same level of bactericidal activity as **flucloxacillin** for this presentation.
Question 30: A 39-year-old man who works as a marine biologist presents with a 5-day history of multiple painless papular lesions on both hands and forearms that have progressed to form violaceous nodules. He reports regular handling of sea urchins and coral samples. The lesions have a verrucous appearance and do not respond to a 3-day course of flucloxacillin. He is otherwise well with no systemic symptoms. What is the most likely causative organism?
A. Mycobacterium marinum (Correct Answer)
B. Erysipelothrix rhusiopathiae
C. Vibrio vulnificus
D. Sporothrix schenckii
E. Nocardia species
Explanation: ***Mycobacterium marinum***
- This infection, known as **Fish Tank Granuloma**, occurs after trauma in marine environments; it characteristically presents as **violaceous nodules** or verrucous plaques on distal extremities.
- The organism grows optimally at **30-32°C**, explaining why it affects cooler areas like the hands and why it fails to respond to standard **beta-lactam antibiotics** like flucloxacillin.
*Erysipelothrix rhusiopathiae*
- Causes **erysipeloid**, which typically presents as a painful, sharply demarcated, diamond-shaped **erythematous plaque** rather than verrucous nodules.
- It is usually very sensitive to **penicillin**, unlike the slow-growing mycobacteria seen in this case.
*Vibrio vulnificus*
- Presents as a **rapidly progressive** and life-threatening cellulitis with **hemorrhagic bullae** and severe systemic toxicity.
- It is frequently associated with **undercooked seafood** or wound exposure to warm seawater in patients with underlying liver disease.
*Sporothrix schenckii*
- Causes **sporotrichosis** (Rose Gardener's Disease), which can share the lymphangitic spread pattern but is linked to **soil, hay, or moss**, not marine life.
- The lesions are usually small, painless papules that eventually **ulcerate**, which differs from the verrucous nodular appearance described.
*Nocardia species*
- Cutaneous **nocardiosis** usually presents with abscesses or cellulitis and is predominantly seen in **immunocompromised** individuals.
- This organism is associated with **soil and organic matter** inoculation, and it does not specifically correlate with the professional marine exposure mentioned.
